Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for ...

MHRA response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025 SAN DIEGO, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a ...
The Kathmandu Post on MSN

Supreme Court halts government's decision to recall 11 Nepali ambassadors

The Supreme Court has issued an interim order against the government's decision to recall 11 Nepali ambassadors from various ...